Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education

Intest Res. 2022 Oct;20(4):389-391. doi: 10.5217/ir.2022.00117. Epub 2022 Oct 28.
No abstract available

Publication types

  • Editorial
  • Comment